Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2026, issued by M/s. MUFG Intime India Private Limited, Registrar & Share Transfer Agent of the Company.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has submitted the Exchange a copy of the Scrutinizers report of the Annual General Meeting held on September 24, 2026, and informed the Exchange regarding voting results.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited held its 38th Annual General Meeting on September 24, 2026, through video conferencing. The meeting approved the audited financial statements for the year ended March 31, 2026, and declared a dividend of Rs. 4.00 per equity share. The company also re-appointed retiring directors Prof. (Dr.) Mahesh Verma and Dr. Suneeta Reddy. The meeting concluded with a vote of thanks to the chair.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange about the closure of the trading window for designated persons, including promoters, directors, and key managerial personnel, from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange about a copy of newspaper publication regarding the transfer of shares to IEPF.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange about the publication of a public notice of the 38th Annual General Meeting in the Financial Express and Jansatta newspapers.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026, along with the Annual Report for the financial year ended 31st March, 2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has announced the record date for the purpose of dividend declaration as 18-Sep-2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange about General Updates, including the 38th Annual General Meeting (AGM) on September 24, 2026, record date for dividend on September 18, 2026, and cut-off date for remote e-voting on September 18, 2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange about the publication of their financial results in the 'Financial Express' and 'Jansatta' newspapers.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has announced its un-audited financial results for the quarter ended 30th June, 2026, and has also approved the re-appointment of its cost auditors for the financial year 2026-27. The company has also fixed the record date for determining the names of shareholders entitled for the dividend for the year 2025-26 and for the Annual General Meeting.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has announced the record date for the purpose of dividend and meeting as 18-Sep-2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has announced its un-audited financial results for the quarter ended June 30, 2026, and has also approved the convening of its 38th Annual General Meeting on September 24, 2026, and fixed the record date for determining shareholder entitlement for the dividend for the year 2025-26 as September 18, 2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2026.

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, Key Managerial Personnel, Designated Employees and their connected persons from Wednesday, 1st July, 2026, till 48 hours after the announcement/ declaration of the un-audited financial results.

Indraprastha Medical Corporation Limited

Apollo Hospitals Enterprise Limited, the promoter of Indraprastha Medical Corporation Limited, has submitted a disclosure to the exchanges. This filing is made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation specifically requires promoters to disclose details of any shares they or persons acting in concert have encumbered (pledged or charged). While the specific figures of the encumbrance are not detailed in this announcement, investors should note that the promoter has made a disclosure related to pledged shares. This information is important as encumbered shares can indicate financial leverage and potential impacts on promoter shareholding stability.